Beyond X-Ray

AISpiration olfactory sensor products and services have been developed to detect lung cancer as early as possible through VOCs data, sensor array, and AI algorithms.

Get Started Ask a question

Early Lung Cancer Diagnosis using Exhaled breath

Development of early diagnosis system for lung cancer based on sensor array and artificial intelligence using exhaled VOCs.

Use as an on-site diagnostic lung cancer early screening device.

Upgrade in Devices and Deep Learning technologies
Increasing number of clinical cases in hospital

AI + Respiration

AISpiration

AISpiration is an ETRI-research institute startup where the Electronics and Telecommunications Research Institute (ETRI) is a Korean government-funded research institution in Korea. ETRI has invested exhaled breath-based E-nose technology for mobile healthcare and developed biomarkers-based healthcare devices. Seoul National University Bundang Hospital (SNUH) conducted clinical trials on lung cancer patients.

AISpiration stands on two giants shoulders and continue to innovate healthcare industry by introducing accurate and convenient healthcare products and services based on big data and AI deep learning technology.

Download corporate brochure .

Interests